Tetrodotoxin for Chemotherapy-Induced Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Dose Finding Trial

Tetrodotoxin (TTX) has emerged as a potentially efficacious agent for chemotherapy-induced neuropathic pain (CINP), a prevalent, debilitating condition often resistant to analgesics. This randomized, double-blind, dose-finding study was undertaken to explore safety and trends in efficacy of four TTX...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldlust, Samuel A., Kavoosi, Mojgan, Nezzer, Jennifer, Kavoosi, Mehran, Korz, Walter, Deck, Kenneth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064362/
https://www.ncbi.nlm.nih.gov/pubmed/33805908
http://dx.doi.org/10.3390/toxins13040235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064362/
https://www.ncbi.nlm.nih.gov/pubmed/33805908
http://dx.doi.org/10.3390/toxins13040235

Ejemplares similares